Is MCS Psychological or Physical? The Evidence Says Physical

The evidence points one way. This page sets out what has actually been measured in people with MCS, states the strongest case for a psychological explanation and what it does and does not show, and is honest about what stress really does.

Start with what is not in dispute: your symptoms are real. Nobody writing on this argues otherwise, including the clinicians who think the cause is psychological. The disagreement is about cause — and on the evidence, the side arguing MCS is a physical, body-based condition has the far stronger hand: measurable nerve changes, immune findings, genetics, and symptoms that drop when the air is cleaned. Stress can turn the volume up, as it does in many physical illnesses — but that does not make this “all in your head,” and no current science supports that claim.

Multiple Chemical Sensitivity is often described as contested, and it is worth being precise about what that means. The disagreement is not evenly balanced, and it is not really between two papers. It is between a clinical impression that MCS is psychogenic and a body of measurement — receptor studies, skin biopsies, brain imaging, genetics, and trials of cleaner air — that keeps finding physical differences in people with MCS. This page starts from the measurements. A 2024 clinical perspective in Brain Sciences and the 2025 comment answering it appear here as two of the sources, not as the frame.

The full walk through the evidence: We followed it. Here’s where it leads →

What is MCS, and what is actually in dispute?

People with MCS report real, sometimes disabling symptoms — trouble breathing, racing heart, brain fog, nausea — from everyday low-level exposures most people tolerate. Standard tests usually come back normal, which is much of why the cause stays disputed.

What has actually been measured in people with MCS?

Start here, because this is what the question turns on. Below are the findings that have actually been measured in people diagnosed with MCS — receptor and mechanism reviews, skin biopsy, brain imaging, genetics, and a trial in which symptoms fell when the air was cleaned. These are the primary studies. A 2025 Comment letter in Brain Sciences (Psaradellis) gathers several of them, but it is a two-page letter rather than a study, and this page rests on the work itself rather than on the letter.

The Position

MCS is a real, physical, multi-system condition with measurable biological signatures. Psychology matters — but mostly as the emotional toll of living with a stigmatized illness, not as its cause.

The rebuttal builds its case on five separate lines of evidence:

  • Measurable body changes. MCS patients show objective physical markers — elevated oxidative stress, altered brain activation, and “receptor sensitization”: the nerve channels that sense irritants (called TRPV1 and TRPA1) become over-reactive. The paper notes that 21 separate receptor-challenge studies (19 capsaicin, 2 acrolein) point to this receptor sensitization as a key mechanism.
  • Remove the chemical, symptoms drop. A clinical study found that improving indoor air quality by cutting volatile organic compounds (VOCs) produced significant symptom improvement. A purely psychological condition would not be expected to respond so directly to cleaning up the air.
  • Genetics. Certain inherited gene variants raise the odds of MCS. Carriers of the active and rapid variants of two chemical-processing genes (CYP2D6 and NAT2) — faster metabolism, not slower — showed three- to four-fold higher odds of having the condition in the original study — real, biologically plausible evidence, though later attempts to replicate it have been inconsistent (one follow-up found the NAT2 association held only in the most severely affected patients). Newer 2025 genetic findings elsewhere in the field continue to build the broader case independently.
  • Immune involvement. In a survey of over 10,000 U.S. adults, people with the highest markers of mast cell activation (an immune-system response) had more than six times the odds of chemical intolerance — tying MCS to a concrete immune mechanism.
  • Official and legal recognition. Germany, Japan, and Spain formally recognize MCS as an environmental health condition with official ICD-10 diagnostic codes, and several Canadian workplace-accommodation rulings have accepted its physical basis.

A direct hit on the 2024 evidence. The rebuttal’s sharpest point is about Jacques’s case studies: it argues two of the three actually describe carbon monoxide poisoning — a completely different condition from MCS — and that the paper never explains how those cases were selected, which weakens them as support for a psychological model.

What is the psychological explanation, and who makes it?

Source: Jacques, L. “Multiple Chemical Sensitivity: A Clinical Perspective.” Brain Sciences, 2024, 14(12), 1261. A single-author clinical perspective from an occupational and environmental medicine clinic at a Montreal university hospital. It is an argument from the literature and from clinical experience — not a study, and it reports no new measurements.

The Position

MCS develops mainly out of unresolved emotional trauma and the body’s chronic and acute stress reactions. In this view, the symptoms are real but the engine driving them is psychological, not the chemicals themselves.

How it is argued. The paper reviews the published literature alongside the author’s own clinical experience, then compares brain-imaging and biomarker findings in MCS patients against findings in the conditions that frequently travel with MCS — many of which are psychiatric, such as anxiety and depression. It illustrates the model with three patient case studies.

What it implies. If trauma and stress are the root, the most effective help is psychological and stress-directed — retraining the stress response rather than chasing the chemicals.

Where the two published commentaries stand

Two short opinion pieces in Brain Sciences argue over the evidence above. Neither reports a measurement of its own. They are set out here because they are frequently quoted, not because the question rests on them.

The psychogenic case (Jacques, 2024)

Paper: Jacques (2024), Brain Sci. 14:1261

Core claim: MCS is primarily psychogenic — driven by unresolved emotional trauma and chronic stress responses.

Main evidence: Literature review plus clinical experience; comparison with psychiatric comorbidities; three patient case studies.

Treatment implication: Target the mind and stress response (psychological and stress-directed therapies).

The physical, multi-system case (Psaradellis, 2025)

Paper: Psaradellis (2025), Brain Sci. 15:747 — a Comment replying to Jacques

Core claim: MCS is a genuine physical condition with measurable biology; it cannot be reduced to psychology.

Main evidence: Receptor and oxidative-stress studies, a VOC-reduction trial, genetic and immune (mast-cell) data, legal rulings, and ICD-10 recognition abroad.

Treatment implication: Reduce chemical exposure and treat the underlying biology; address psychology as a consequence, not the cause.

The strongest evidence for a psychological explanation — and what it does and doesn’t show

The strongest case for a psychological explanation is the provocation literature, and it deserves to be stated in full before it is answered.

In 2006, Das-Munshi, Rubin and Wessely published a systematic review of thirty-seven provocation studies covering 784 people with MCS and 547 controls. When the chemical was masked so it could not be smelled, people with MCS could not reliably tell chemical from sham. In those same studies, people with MCS reacted more than controls to both the chemical and the sham. The review itself acknowledged that blinding was inadequate in most of the studies it examined.

A 2008 reanalysis by Goudsmit and Howes went back through the cleanest negative studies and found that two of the three had selected their subjects by self-reported belief that they were chemically sensitive rather than by diagnosis, and concluded that the psychological case had been overstated.

And the point that limits every one of those studies: every provocation subject already had MCS. The studies show that expectation shapes the reaction once the condition exists — which is what a sensitized alarm system does — and they say nothing about what starts it. Two pages take this apart study by study: The strongest evidence that MCS is psychological — and why it doesn’t settle the question and What the 2006 provocation review actually found.

What is not in dispute, and where the disagreement really sits

Both sides actually agree on one mechanism: sensitization. Something tips the body into an over-reactive state, so tiny exposures set off an outsized alarm. The argument is about what trips it, not whether it's real.

Where the disagreement actually sits. The psychogenic explanation says the trigger is in the mind — trauma and a stuck stress response, reaching the body from there. The physical account says the trigger is chemical exposure acting on sensitized nerves, genes and the immune system, and that this reaches the mind from there. Same symptoms, opposite direction of travel.

Where the evidence lands. Not evenly. The physical account is the one carrying measurements — genetic data, receptor studies, immune findings, skin biopsy, brain imaging, and a trial in which symptoms fell when the air was cleaned. The psychogenic account is pointing at something real that the physical side tends to underweight, which is the well-documented way stress and emotional state amplify symptoms. But amplifying a signal is not the same as creating it, and the case for the trigger itself rests on case studies rather than measurement.

The Mature Reading

These are not two incompatible diseases. They are two inputs into the same sensitized system. For most patients both matter — a physical trigger sets the condition up, and stress or emotional state turns the volume up or down. The evidence settles the direction: in MCS as defined by the consensus criteria, the condition is physiological and environmentally triggered, and psychological factors modify the response once it exists. What is not settled is the mechanism inside the body. A source that presents the two views as equals is overstating the psychological case, not being balanced.

What should you know about who wrote these two commentaries?

Both Brain Sciences pieces are single-author opinion articles. Neither reports an experiment, a cohort or a measurement. That matters more than either author’s affiliation, and it is why this page is built on the primary studies instead:

  • Jacques writes from occupational and environmental medicine, a field with a long-standing skepticism of MCS as a physical disease. The paper declares no competing interest. It is a clinical perspective — one physician’s reading of the literature alongside his own practice.
  • Psaradellis writes from the Environmental Health Association of Québec, a patient-advocacy organization with a direct stake in MCS being classified as physical. We state that plainly rather than let a reader find it. It is also a two-page Comment letter, which is why this page cites the studies it points to rather than the letter itself.

So do not weigh one commentary against the other. Weigh the underlying studies, which is what the rest of this page does — and when you do, the physical findings are the ones with measurements behind them.

If You Only Remember Four Things

  • MCS symptoms are real and can be disabling — that is not in dispute.
  • The weight of the evidence supports a physical, multi-system cause (nerves, genes, immune system), not a purely psychological one.
  • Stress and emotional state clearly influence symptoms, which is why mind-and-stress approaches sometimes help — but that does not make the condition “all in your head.”
  • Reducing chemical exposure has measurable benefit, so cleaning up a person’s environment is a legitimate, evidence-backed step.

Frequently Asked

Is MCS real?

Yes. The symptoms are real and can be disabling — that is not in dispute between either side of the clinical debate. What was debated is the cause, and the weight of the evidence supports a physical, multi-system mechanism.

Is MCS psychological?

A purely psychological cause is not supported by current science. People with MCS show measurable changes in their nerves, genes, and immune system, and symptoms fall when chemical exposure is reduced. Stress and emotional state can amplify symptoms, but that is an input that turns the volume up or down — not the root cause.

Does reducing chemical exposure help?

Yes. A clinical study found that improving indoor air quality by cutting volatile organic compounds (VOCs) produced significant symptom improvement. A purely psychological condition would not be expected to respond so directly to cleaning up the air, which is one of the strongest pieces of evidence for a physical mechanism.

Key Studies Referenced

The two papers in the debate:

1 Jacques, L. (2024). Multiple Chemical Sensitivity: A Clinical Perspective. Brain Sciences, 14(12), 1261. PMID: 39766460. doi:10.3390/brainsci14121261
2 Psaradellis, E. (2025). Redefining Clinical Perspectives on MCS: Toward an Evidence-Based, Multisystem Model. Comment on Jacques (2024). Brain Sciences, 15(7), 747. PMID: 40722338. doi:10.3390/brainsci15070747

The primary studies the rebuttal relies on:

3 Molot, J., Sears, M., & Anisman, H. (2023). Multiple Chemical Sensitivity: It’s time to catch up to the science. Neuroscience & Biobehavioral Reviews, 151, 105227. (Synthesis of receptor-sensitization and oxidative-stress evidence.)
4 Perales RB, Palmer RF, Rincon R, et al. (2022). Does improving indoor air quality lessen symptoms associated with chemical intolerance? Primary Health Care Research & Development, 23, e3. (VOC-reduction symptom study.)
5 McKeown-Eyssen, G., Baines, C., Cole, D. E., et al. (2004). Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. International Journal of Epidemiology, 33, 971–978. (Genetic susceptibility.)
6 Miller, C. S., Palmer, R. F., Kattari, D., et al. (2023). What initiates chemical intolerance? Findings from a large population-based survey of U.S. adults. Environmental Sciences Europe, 35, 65. (Mast-cell / immune link.)
7 Palmer, R. F., Almeida, M., Perales, R. B., & Rincon, R. (2023). A genome-wide SNP investigation of chemical intolerance. Environmental Advances, 12, 100380. (Gene–environment interaction.)
8 McKeown-Eyssen, G. E., Baines, C. J., Marshall, L. M., et al. (2001). Multiple chemical sensitivity: Discriminant validity of case definitions. Archives of Environmental Health, 56, 406–412. (The 1999 consensus definition used to flag the misclassified case studies.)

Medical Disclaimer

This summary is for general information and discussion. It is not medical advice and does not diagnose or treat any condition. Claims are drawn from the published papers cited above; readers are encouraged to consult the original sources and work with healthcare providers familiar with environmental illness.

← Back to MCSDisability.com
↑